UnitedHealth stock edges higher after positive earnings guidance but faces fatigue at resistance: weekly analysis

UnitedHealth stock edges higher after positive earnings guidance but faces fatigue at resistance: weekly analysis
UnitedHealth Group rises 2.19% this week

Shares of UnitedHealth Group (UNH) are trading near $404 after rising over 2% this week as buyers attempt to regain control but face signs of fatigue. The technical setup is mixed, with a persistent uptrend but neutral momentum gauges, leaving the market searching for direction as the tug-of-war between bulls and bears continues into the new week.

UNH price prediction
24H 0.06%
$340.21
48H -0.19%
$339.39
7D -1.61%
$334.55
1M 2.22%
$347.56
3M 2.99%
$350.18
6M -16.11%
$285.25
12M 11.89%
$380.46
Current price: $340.02 9.54 2.89%
Closed 11/20
Daily range 338.24 Arrow from to Icon 347.45
Weekly range 324.67 Arrow from to Icon 415.19
Loading...

Highlights

  • Shares of UnitedHealth have gained $9.71 or 2.19% over the past seven days, trading at $404.02.
  • The stock maintains a bullish long-term structure with trend strength confirmed by technical indicators and a strong buy forecast.
  • Price is expected to trade between $392.67 and $426.23 in the next five days, with resistance at $407.48 and support at $397.53.

Earnings guidance boost and bid rejection lift sentiment amid leadership change

UnitedHealth raised its full-year earnings guidance for the third time this year after posting a strong third-quarter report, according to Yahoo Finance. The company reported adjusted earnings of $4.69 per share for the quarter, indicating margin repair is underway despite flat revenues. Surgery Partners reportedly rejected an unsolicited $28 per share takeover bid from UNH, while Madeline S. Bell, former CEO of the Children's Hospital of Philadelphia, was immediately appointed to the board on November 9, 2026.

UnitedHealth Group Incorporated asset chart
UnitedHealth Group Incorporated price dynamics. Source: TradingView.

Bullish MACD and firm trend counter neutral momentum as volatility persists

The daily chart reflects a sustained move higher with a firm trend, as indicated by a bullish MACD (2.17, forecast: Strong Buy) and an ADX reading of 25.78, confirming trend strength. Oscillator readings are neutral, with the RSI at 51.27 and Stochastic RSI also in a non-extreme position. Volatility remains elevated at 6.51% for the week. Key levels to watch are support at the Ichimoku Kijun of $397.53 and resistance at the 20-day average near $407.48, as the price is currently trading between these markers.

Upside breakout risk high as price tests range boundaries next week

For the next five trading days, the expected range is $392.67 to $426.23. There is a very high probability (more than 80%) of an upward move, and a very low probability (less than 20%) of a decline. The base scenario is for the stock to trade between $397.53 and $407.48. A confirmed move above $407.48 would open the path toward the upper end of the projected range, while loss of support at $397.53 would expose the lower boundary.

Sholanke Dele, market strategist, views the latest action in UnitedHealth Group shares as signaling a tense standoff between buyers and sellers. He notes that while the stock gained over 2% this week and the company raised earnings guidance after a solid report, neutral oscillator readings and lingering volatility point to caution. Macro sentiment remains mixed, with margin repair underway but revenue growth stalling and recent M&A developments failing to tip the balance. Dele sees the immediate technical range between $397.53 support and $407.48 resistance as pivotal, and warns that the base scenario is for sideways trade barring a firm break above or below these levels. "Until shares convincingly clear $407.48, I remain cautious and see no strong upside catalyst heading into the week."

Previously it was reported that UnitedHealth's share price faced pronounced selling pressure despite solid earnings and an expanded buyback program, with technical levels providing crucial support. In light of the latest earnings guidance upgrade, sustained uptrend, and new board appointment, traders should now focus on whether the price can decisively break above the $407.48 resistance to unlock further upside potential in the coming week.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.